These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6825048)

  • 21. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
    Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
    Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis.
    Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J
    Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study.
    Xiao J; Ye ZS; Wei SH; Zeng Y; Lin ZM; Wang Y; Teng WH; Chen LC
    World J Gastroenterol; 2017 Dec; 23(48):8562-8569. PubMed ID: 29358864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of circulating MAM-6 and CEA levels and correlation with the estrogen receptor in patients with breast cancer.
    Hilkens J; Bonfrer JM; Kroezen V; van Eykeren M; Nooyen W; de Jong-Bakker M; Bruning PF
    Int J Cancer; 1987 Apr; 39(4):431-5. PubMed ID: 3557702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen staining in breast carcinoma by PAP methods compared to CEA and ferritin staining.
    Osamu K; Takashi M; Yohichi T; Yasuo U; Tetsuro Y; Yoshiro F; Toshio T
    Cancer Detect Prev; 1987; 10(1-2):113-20. PubMed ID: 2436774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.
    Shek LL; Godolphin W; Spinelli JJ
    Br J Cancer; 1987 Dec; 56(6):825-9. PubMed ID: 3435707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.
    Raemaekers JM; Beex LV; Koenders AJ; Pieters GF; Smals AG; Benraad TJ; Kloppenborg PW
    Breast Cancer Res Treat; 1985; 6(2):123-30. PubMed ID: 4052639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
    Paulick R; Caffier H
    Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of DNA content in relation to histological type, ER and CEA in primary breast carcinoma].
    Huang XC
    Zhonghua Bing Li Xue Za Zhi; 1990 Dec; 19(4):264-7. PubMed ID: 1964400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.
    Mori M; Mimori K; Ueo H; Tsuji K; Shiraishi T; Barnard GF; Sugimachi K; Akiyoshi T
    J Clin Oncol; 1998 Jan; 16(1):128-32. PubMed ID: 9440733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
    Shao Y; Sun X; He Y; Liu C; Liu H
    PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors influencing on the prognosis in breast cancer].
    Taguchi T; Horino T; Ota J
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2043-9. PubMed ID: 2456037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
    Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
    Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
    Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer.
    Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR
    JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival with breast cancer: the importance of estrogen receptor quantity.
    Shek LL; Godolphin W
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):243-50. PubMed ID: 2702979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis.
    Cañizares F; Sola J; Pérez M; Tovar I; De Las Heras M; Salinas J; Peñafiel R; Martínez P
    Tumour Biol; 2001; 22(5):273-81. PubMed ID: 11553856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.